(2R,4R)-tert-Butyl 2-(fluoromethyl)-4-hydroxypyrrolidine-1-carboxylate, 95+%, 5g

Regorafénib N-oxyde (M2), 1mg

2-Iodo-4-(trifluoromethyl)thiazole, 97%, 500mg

(R)-(4-(1-AMINOETHYL)PHENYL)METHANOL, 95.0%, 1g

Propynol ethoxylate, min. 98%, for synthesis, 500 ml, glass packaging

5-Nitro-2-(pyrrolidin-1-yl)benzoic acid, 95.0%, 1g

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid dihydrate, 95.0%, 5g

2-Methyl-3,5-dinitrobenzoic acid, 98%, 25g

N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride, 95.0%, 100g

4-(Difluoromethoxy)nitrobenzene, 97.0%, 100g

6-Methoxyquinoline-2-carboxylic acid, 95.0%, 500mg

4-Chlorobenzenesulfinic acid sodium salt, 95.0%, 25g

2,5-Dibromopyridin-4-amine, 95.0%, 250mg